Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other Working Capital Changes (2019 - 2025)

Eton Pharmaceuticals' Other Working Capital Changes history spans 7 years, with the latest figure at $122000.0 for Q3 2025.

  • For Q3 2025, Other Working Capital Changes fell 23.27% year-over-year to $122000.0; the TTM value through Sep 2025 reached $3.0 million, up 513.64%, while the annual FY2024 figure was $3.3 million, 3662.77% up from the prior year.
  • Other Working Capital Changes for Q3 2025 was $122000.0 at Eton Pharmaceuticals, down from $2.3 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $3.5 million in Q4 2024 and bottomed at -$3.0 million in Q1 2025.
  • The 5-year median for Other Working Capital Changes is -$79000.0 (2024), against an average of $99526.3.
  • The largest annual shift saw Other Working Capital Changes soared 1400.0% in 2021 before it crashed 3663.29% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at $743000.0 in 2021, then plummeted by 61.1% to $289000.0 in 2022, then skyrocketed by 126.64% to $655000.0 in 2023, then soared by 437.4% to $3.5 million in 2024, then tumbled by 96.53% to $122000.0 in 2025.
  • Per Business Quant, the three most recent readings for ETON's Other Working Capital Changes are $122000.0 (Q3 2025), $2.3 million (Q2 2025), and -$3.0 million (Q1 2025).